Dopamine Autoreceptor Sensitivity is Unchanged in Rat Nucleus Accumbens After Chronic Haloperidol Treatment: An In Vivo and In Vitro Voltammetric Study

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Journal of Neuroscience

• Publication date

  1995-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1460-9568.1995.tb01043.xPMID 8845950
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol

  2005cited by this paper
• Bromocriptine and apomorphine stimulation of cortisol secretion in conscious dogs; evidence for a stimulatory site located outside the blood brain barrier

  2004cited by this paper
• Stimulus-evoked dopamine overflow in the rat nucleus accumbens is decreased following chronic haloperidol administration: an in vivo voltammetric study.

  1995cited by this paper
• ApoE genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val-->Ile mutated families.

  1995cited by this paper
• Fast electrochemical studies in isolated tissues.

  1995cited by this paper
• Functional expression and characterization of human D2 and D3 dopamine receptors

  1994cited by this paper
• Failure of chronic haloperidol to induce depolarization inactivation of dopamine neurons in unanesthetized rats.

  1994cited by this paper
• Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors.

  1994cited by this paper
• Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.

  1994cited by this paper
• Dopamine receptors: molecular biology, biochemistry and behavioural aspects.

  1994cited by this paper
• The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain

  1994cited by this paper
• The NMDA Receptor Antagonist CPP Suppresses Long‐term Potentiation in the Rat Hippocampal — accumbens Pathway In Vivo

  1994cited by this paper
• Ventral tegmental area (VTA) injections of tyrosine hydroxylase phosphorothioate antisense oligonucleotide suppress operant behavior in rats.

  1994cited by this paper
• Expression and pharmacological characterization of the human D3 dopamine receptor.

  1994cited by this paper
• Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations

  1994cited by this paper
• Dopamine D2 and D3 receptors inhibit dopamine release.

  1994cited by this paper
• Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.

  1994cited by this paper
• High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.

  1994cited by this paper
• Differential Visualization of Dopamine D2 and D3 Receptor Sites in Rat Brain. A Comparative Study Using In Situ Hybridization Histochemistry and Ligand Binding Autoradiography

  1993cited by this paper
• Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system

  1993cited by this paper
• Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum.

  1993cited by this paper
• Stress‐Induced Dopamine Release in the Neostriatum: Evaluation of the Role of Action Potentials in Nigrostriatal Dopamine Neurons or Local Initiation by Endogenous Excitatory Amino Acids

  1993cited by this paper
• Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo.

  1993cited by this paper
• A quantitative estimate of the role of striatal D-2 receptor proliferation in dopaminergic behavioral supersensitivity: the contribution of mesolimbic dopamine to the magnitude of 6-OHDA lesion-induced agonist sensitivity in the rat.

  1993cited by this paper
• Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation.

  1993cited by this paper
• Increases in tyrosine hydroxylase messenger RNA in the locus coeruleus after a single dose of nicotine are followed by time-dependent increases in enzyme activity and noradrenaline release.

  1993cited by this paper
• Developments in the drug treatment of schizophrenia.

  1992cited by this paper
• Effects of Dopaminergic Transmission Interruption on the D2 Receptor Isoforms in Various Cerebral Tissues

  1992cited by this paper
• The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.

  1992cited by this paper
• Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects.

  1992cited by this paper
• Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors

  1992cited by this paper
• The dopamine receptor family: molecular biology and pharmacology

  1992cited by this paper
• Regional differences in chronic neuroleptic effects on extracellular dopamine activity.

  1992cited by this paper
• Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study.

  1991cited by this paper
• “Real time” measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens : role of autoinhibition

  1991cited by this paper
• Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

  1990cited by this paper
• Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.

  1990cited by this paper
• Presynaptic Receptors on Catecholamine Neurones

  1988cited by this paper
• Stimulated limbic and striatal dopamine release measured by fast cyclic voltammetry: anatomical, electrochemical and pharmacological characterisation.

  1988cited by this paper
• Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo.

  1987cited by this paper
• D-2 dopamine-receptors regulate the release of [3H]dopamine in rat cortical regions showing dopamine immunoreactive fibers.

  1987cited by this paper
• Implications of normal brain development for the pathogenesis of schizophrenia.

  1987cited by this paper
• Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording.

  1986cited by this paper
• Neurochemical Profile of Lu 19‐005, a Potent Inhibitor of Uptake of Dopamine, Noradrenaline, and Serotonin

  1985cited by this paper
• Prolonged antidopaminergic actions of single doses of butyrophenones in the rat

  1985cited by this paper
• Chemotherapy in psychiatry : principles and practice

  1985cited by this paper
• Pharmacology of nomifensine: a review of animal studies.

  1984cited by this paper
• Carbon fibre microelectrodes.

  1979cited by this paper
• Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro

  1978cited by this paper
• Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors.

  1977cited by this paper
• Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain.

  1977cited by this paper
• Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

  1974cited by this paper

• Dopaminergic mechanisms underlying the expression of antipsychotic-induced dopamine supersensitivity in rats.

  2021cites this paper
• Where and how does d-amphetamine act to reveal antipsychotic-induced dopamine supersensitivity in rats?

  2020cites this paper
• Antipsychotic-evoked dopamine supersensitivity.

  2020cites this paper
• Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy

  2017cites this paper
• Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment

  2017cites this paper
• Can antipsychotic treatment contribute to drug addiction in schizophrenia?

  2014cites this paper
• Estudio funcional del receptor dopaminérgico D2 en el sistema nervioso central mediante el uso de ratones mutantes inducibles

  2012cites this paper
• fMRI of Cocaine Self-Administration in Macaques Reveals Functional Inhibition of Basal Ganglia

  2011cites this paper
• “Breakthrough” Dopamine Supersensitivity during Ongoing Antipsychotic Treatment Leads to Treatment Failure over Time

  2007influential citation
• Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens.

  2006cites this paper
• Tyrosine hydroxylase mRNA and protein are down‐regulated by chronic clozapine in both the mesocorticolimbic and the nigrostriatal systems

  2003cites this paper
• Striatal Extracellular Dopamine Levels in Rats with Haloperidol-Induced Depolarization Block of Substantia Nigra Dopamine Neurons

  1998cites this paper
• Monitoring brain chemistry in vivo: voltammetric techniques, sensors, and behavioral applications.

  1998cites this paper
• Functional Roles of Dopamine D2 and D3Autoreceptors on Nigrostriatal Neurons Analyzed by Antisense KnockdownIn Vivo

  1997cites this paper
• Chronic clozapine versus chronic haloperidol treatment: differential effects on electrically evoked dopamine efflux in the rat caudate putamen, but not in the nucleus accumbens

  1996influential citation